Financial results - SOLIUS PHARM SRL

Financial Summary - Solius Pharm Srl
Unique identification code: 33724280
Registration number: J2014003080237
Nace: 4773
Sales - Ron
611.826
Net Profit - Ron
13.820
Employees
6
Open Account
Company Solius Pharm Srl with Fiscal Code 33724280 recorded a turnover of 2024 of 611.826, with a net profit of 13.820 and having an average number of employees of 6. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Solius Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 25.058 28.051 153.776 231.388 359.140 332.494 479.294 585.403 674.904 611.826
Total Income - EUR 25.058 28.051 153.789 231.548 359.217 332.585 479.327 585.403 674.904 611.826
Total Expenses - EUR 37.119 45.409 140.887 209.621 304.024 300.216 404.633 514.957 583.066 594.533
Gross Profit/Loss - EUR -12.061 -17.358 12.902 21.927 55.193 32.369 74.694 70.447 91.837 17.293
Net Profit/Loss - EUR -12.827 -17.639 11.364 19.611 51.588 29.295 70.474 64.707 79.162 13.820
Employees 2 2 1 3 4 3 3 4 5 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -8.8%, from 674.904 euro in the year 2023, to 611.826 euro in 2024. The Net Profit decreased by -64.900 euro, from 79.162 euro in 2023, to 13.820 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Solius Pharm Srl

Rating financiar

Financial Rating -
SOLIUS PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Solius Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Solius Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Solius Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Solius Pharm Srl - CUI 33724280

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 831 31 0 40 5.573 3.800 2.085 28.298 20.521 11.962
Current Assets 21.784 33.083 64.253 82.751 96.771 119.445 192.261 214.228 354.489 429.826
Inventories 19.052 28.431 45.769 71.377 90.705 104.233 119.366 169.416 281.338 363.982
Receivables 2.542 3.916 1.964 6.257 2.974 9.398 29.990 39.763 63.250 62.415
Cash 190 737 16.520 5.117 3.092 5.814 42.905 5.049 9.902 3.428
Shareholders Funds -14.045 -31.540 -19.643 329 51.910 80.221 148.916 64.756 143.721 156.738
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 36.660 64.655 83.895 82.461 50.433 43.024 45.430 177.771 231.289 285.050
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 429.826 euro in 2024 which includes Inventories of 363.982 euro, Receivables of 62.415 euro and cash availability of 3.428 euro.
The company's Equity was valued at 156.738 euro, while total Liabilities amounted to 285.050 euro. Equity increased by 13.820 euro, from 143.721 euro in 2023, to 156.738 in 2024.

Risk Reports Prices

Reviews - Solius Pharm Srl

Comments - Solius Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.